Staphylococcus aureus requires branched-chain amino acids (BCAAs; isoleucine, leucine, valine) for protein synthesis, branched-chain fatty acid synthesis, and environmental adaptation by responding to their availability via the global transcriptional regulator CodY. The importance of BCAAs for S. aureus physiology necessitates that it either synthesize them or scavenge them from the environment. Indeed S. aureus uses specialized transporters to scavenge BCAAs, however, its ability to synthesize them has remained conflicted by reports that it is auxotrophic for leucine and valine despite carrying an intact BCAA biosynthetic operon. In revisiting these findings, we have observed that S. aureus can engage in leucine and valine synthesis, but the level of BCAA synthesis is dependent on the BCAA it is deprived of, leading us to hypothesize that each BCAA differentially regulates the biosynthetic operon. Here we show that two mechanisms of transcriptional repression regulate the level of endogenous BCAA biosynthesis in response to specific BCAA availability. We identify a trans-acting mechanism involving isoleucine-dependent repression by the global transcriptional regulator CodY and a cis-acting leucine-responsive attenuator, uncovering how S. aureus regulates endogenous biosynthesis in response to exogenous BCAA availability. Moreover, given that isoleucine can dominate CodY-dependent regulation of BCAA biosynthesis, and that CodY is a global regulator of metabolism and virulence in S. aureus, we extend the importance of isoleucine availability for CodY-dependent regulation of other metabolic and virulence genes. These data resolve the previous conflicting observations regarding BCAA biosynthesis, and reveal the environmental signals that not only induce BCAA biosynthesis, but that could also have broader consequences on S. aureus environmental adaptation and virulence via CodY., Author summary To infect its human host, the bacterial pathogen Staphylococcus aureus must either take up nutrients from the surrounding environment or produce them itself. Previous studies have reported that S. aureus does not produce the amino acids leucine and valine, despite it possessing the genes to do so. In this study, we show that S. aureus does indeed produce leucine and valine, but only under certain nutritional conditions. We select for mutants of S. aureus able to grow in valine-depleted environments to uncover genetic variants that enable valine production. We discover genetic variants in a repressor protein and a region of non-coding DNA that both, when properly functioning, inhibit production of leucine and valine under nutrient-rich conditions. We further identify the nutritional conditions where the inhibition of leucine and valine production is relieved, thus revealing a previously overlooked role for another amino acid, isoleucine, in influencing nutrient metabolism. We show that isoleucine levels also influence expression of genes involved in the ability of S. aureus to cause disease. These findings help to reconcile conflicting reports regarding leucine and valine production in S. aureus and reveal nutritional cues that could influence its ability to cause infection.